A feasibility study of low-dose, prolonged oral topotecan in patients with advanced ovarian, fallopian tube, or primary peritoneal serous cancer who have attained a complete clinical response following platinum-based chemotherapy. [electronic resource]
Producer: 20080325Description: 51-8 p. digitalISSN:- 1525-1438
- Administration, Oral
- Adult
- Aged
- Antineoplastic Agents -- administration & dosage
- Carcinosarcoma -- drug therapy
- Cystadenocarcinoma, Serous -- drug therapy
- Fallopian Tube Neoplasms -- drug therapy
- Feasibility Studies
- Female
- Humans
- Middle Aged
- Organoplatinum Compounds -- therapeutic use
- Ovarian Neoplasms -- drug therapy
- Peritoneal Neoplasms -- drug therapy
- Remission Induction
- Topotecan -- administration & dosage
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.